Insights

Rapid Innovation Adoption Nuclera's recent launch of its membrane protein workflow and integration with Cytiva’s surface plasmon resonance technology indicate a strategic focus on expanding its product offerings. This provides sales opportunities to offer complementary tools and services that enhance or complement their innovative eProtein Discovery system.

Growing Investment and Expansion With a substantial Series C financing round totaling $87 million and recent notable investments from British Patent Capital, Nuclera is in a growth phase. This suggests opportunities to engage with the company to introduce advanced research reagents, customized solutions, or new technology partnerships aligned with their expansion plans.

Focus on Membrane Proteins The addition of membrane protein workflows signifies Nuclera's dedication to challenging and high-value targets in protein research. Sales prospects include specialized reagents, sample prep tools, or innovative screening platforms tailored to membrane protein analysis and characterization.

Strategic Collaborations Nuclera's collaborations with Cytiva highlight an openness to integrating and co-developing cutting-edge biotechnologies. This presents an opportunity to propose integrative solutions, software tools, or data management services that streamline their multiplex screening and analysis processes.

Market Presence and Growth With over 100 employees and offices in Cambridge and Boston, Nuclera is positioned as a competitive player in a growing biotech market. Pitching scalable automation solutions, high-throughput tools, or supply chain services could help support their scaling efforts and accelerate customer delivery.

Nuclera Tech Stack

Nuclera uses 8 technology products and services including Salesforce, Oracle Database, Salesforce B2B Commerce, and more. Explore Nuclera's tech stack below.

  • Salesforce
    Customer Relationship Management
  • Oracle Database
    Database
  • Salesforce B2B Commerce
    E-commerce Platforms
  • Apple iCloud Mail
    Email
  • GitLab
    Issue Trackers
  • Web Vitals
    Javascript Libraries
  • ipify
    Mapping And Gis
  • Nginx
    Web Servers

Media & News

Nuclera's Email Address Formats

Nuclera uses at least 1 format(s):
Nuclera Email FormatsExamplePercentage
FLast@nuclera.comJDoe@nuclera.com
98%
FMiddleLast@nuclera.comJMichaelDoe@nuclera.com
1%
Last@nuclera.comDoe@nuclera.com
1%

Frequently Asked Questions

Where is Nuclera's headquarters located?

Minus sign iconPlus sign icon
Nuclera's main headquarters is located at Chivers Way Cambridge, England United Kingdom. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is Nuclera's official website and social media links?

Minus sign iconPlus sign icon
Nuclera's official website is nuclera.com and has social profiles on LinkedInCrunchbase.

What is Nuclera's SIC code NAICS code?

Minus sign iconPlus sign icon
Nuclera's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Nuclera have currently?

Minus sign iconPlus sign icon
As of February 2026, Nuclera has approximately 135 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Chief Commercial Officer (cco): J. B.Chief Financial Officer: S. B.Chief Information Security Officer: A. Z.. Explore Nuclera's employee directory with LeadIQ.

What industry does Nuclera belong to?

Minus sign iconPlus sign icon
Nuclera operates in the Biotechnology Research industry.

What technology does Nuclera use?

Minus sign iconPlus sign icon
Nuclera's tech stack includes SalesforceOracle DatabaseSalesforce B2B CommerceApple iCloud MailGitLabWeb VitalsipifyNginx.

What is Nuclera's email format?

Minus sign iconPlus sign icon
Nuclera's email format typically follows the pattern of FLast@nuclera.com. Find more Nuclera email formats with LeadIQ.

How much funding has Nuclera raised to date?

Minus sign iconPlus sign icon
As of February 2026, Nuclera has raised $43M in funding. The last funding round occurred on Feb 02, 2022 for $43M.

When was Nuclera founded?

Minus sign iconPlus sign icon
Nuclera was founded in 2013.

Nuclera

Biotechnology ResearchEngland, United Kingdom51-200 Employees

Nuclera exists to remove uncertainty from protein science. As the pioneer of multiplex protein screening, we help researchers start with clarity, so ideas move faster to result. We believe access to your protein should be a certainty, not a gamble. eProtein Discovery™ is how we deliver on that promise, but our aim is bigger: to make protein access routine for every lab, accelerate breakthroughs in human health, and empower scientists to spend more time on discovery and less on delay.

Our eProtein Discovery™ system combines unique cell free expression systems, novel digital microfluidics, and robust screening data, to create an effortlessly multiplex protein screening solution that empowers you to perform your own protein screening, characterization, and small-scale expression in-house within days — even challenging membrane proteins

Founded in 2013 by PhD students at the University of Cambridge, the company now has a presence in Cambridge, UK and Boston, MA employing over 100 employees.

Section iconCompany Overview

Headquarters
Chivers Way Cambridge, England United Kingdom
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
51-200

Section iconFunding & Financials

  • $43M

    Nuclera has raised a total of $43M of funding over 1 rounds. Their latest funding round was raised on Feb 02, 2022 in the amount of $43Mas a Series B.

  • $10M$25M

    Nuclera's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $43M

    Nuclera has raised a total of $43M of funding over 1 rounds. Their latest funding round was raised on Feb 02, 2022 in the amount of $43Mas a Series B.

  • $10M$25M

    Nuclera's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.